Where do Summit Therapeutics's ratios come from?

Every ratio is computed from Summit Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on equity	-271%-64.8pp	-206.1%+86.4pp	-292.5%+35.8pp	-328.3%-204pp	-123.9%-29.0pp
Return on assets	-233.8%-51.9pp	-181.9%+59.1pp	-241.1%-17.0pp	-224.1%-138pp	-85.9%-16.6pp
Liquidity
Current ratio	7.4×-2.5×	9.9×+6.1×	3.8×-1.3×	5.1×-5.5×	10.6×+0.5×
Quick ratio	7.4×-2.5×	9.9×+6.1×	3.8×-1.3×	5.1×-5.5×	10.6×+0.5×
Cash ratio	0.1×-0.1×	0.2×+0.1×	0.1×0.0×	0.1×-0.1×	0.2×-0.2×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$0.70-20.1%	$0.88+241%	$0.26-26.0%	$0.35-25.1%	$0.47-13.8%
Valuation
Market capitalization	$14.7B+12.9%	$13.02B-15.2%	$15.35B-1.2%	$15.54B+9.2%	$14.23B+8.1%
Enterprise value	$14.71B+13.0%	$13.02B-15.1%	$15.35B-1.2%	$15.54B+9.2%	$14.23B+8.2%
Price / book	26.9×+7.2×	19.8×-60.1×	79.8×+19.9×	59.9×+18.6×	41.3×+7.5×
Free cash flow yield	-2.6%-0.1pp	-2.5%-0.7pp	-1.8%-0.4pp	-1.3%-0.1pp	-1.2%-0.1pp
Earnings yield	-8.2%+0.1pp	-8.3%-2.3pp	-6%-1.2pp	-4.8%-3.1pp	-1.7%0.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Summit Therapeutics's ratios come from?: Every ratio is computed from Summit Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.